Deal facts
- Buyer
- Mentholatum Australasia Pty Ltd
- Target
- Pain Away
- Deal value
- Not disclosed
- Announced
- 6 August 2026
- Status
- Firm intention
- Sector
- Consumer & Retail
- Country
- Australia
- Consideration
- cash, earn-out
Sources
Mentholatum Australasia Pty Ltd has agreed to acquire Pain Away, a consumer and retail business based in Australia, in a strategic acquisition. The transaction, announced on 6 August 2026, carries a headline offer value of 19.8 million. The consideration structure comprises both cash and earn-out components, reflecting a mixed payment approach typical for such strategic purchases. This deal represents a significant move for the Australian buyer, which is expanding its footprint within the domestic consumer sector through the acquisition of Pain Away. The target operates within the broader consumer and retail industry, positioning it as an attractive asset for strategic growth. Both entities are located in Australia, facilitating a domestic transaction that avoids cross-border complexities. The deal structure suggests a focus on future performance alignment through the earn-out element, while the cash portion provides immediate liquidity. This acquisition highlights the ongoing consolidation and strategic expansion activities within the Australian consumer market.
The transaction remains in the firm intention stage, indicating that definitive agreements have likely been signed but closing conditions are yet to be satisfied. As the deal has not yet completed, the final timeline for integration and operational handover remains pending. Regulatory approvals and other customary closing conditions will need to be met before the acquisition can be finalised. The parties are expected to proceed with the necessary steps to complete the transfer of ownership. Stakeholders will be monitoring the progress closely as the deal moves towards completion. The outcome of this acquisition will likely impact the competitive landscape within the Australian consumer and retail sector. Further details regarding the specific terms of the earn-out and the exact closing date will be disclosed as they become available. The focus now shifts to satisfying the remaining conditions precedent to close the transaction.
More M&A Tools
Explore the Toolkit
Tools, frameworks and AI assistants designed for entrepreneurs serious about M&A.
Access nowDeal timeline
1 update- Firm intention
Sale of Pain Away for up to A$21.3 million
Disclaimer* ASX/AIM Announcement 6 August 2026 Sale of Pain Away for up to A$21.3 million Wellnex Life Limited (ASX/AIM: WNX) (" Wellnex Life " or the " Company ") is pleased to announce it has entered into a formal binding agreement (" Agreement ") to sell
LSE RNS
Explore
Browse adjacent archives
Jump from this deal into the sector, buyer, deal type, and year views that carry the strongest contextual signal.
Similar deals
Similar deals
Other Consumer & Retail M&A activity tracked by Exit Mode.
G III Apparel Group Ltd to acquire Marc Jacobs Holdings, LLC
G III Apparel Group Ltd and Marc Jacobs Holdings, LLC entered the Exit Mode archive.
- Buyer
- G III Apparel Group Ltd
- Target
- Marc Jacobs Holdings, LLC
- Deal value
- Not disclosed
- Deal type
- strategic acquisition
KESKO to acquire DAHL (DENMARK, NORWAY, SWEDEN)
KESKO and DAHL (DENMARK, NORWAY, SWEDEN) entered the Exit Mode archive.
- Buyer
- KESKO
- Target
- DAHL (DENMARK, NORWAY, SWEDEN)
- Deal value
- Not disclosed
- Deal type
- strategic acquisition
cbdMD, Inc. to acquire Twinlab Consolidated Holdings, Inc.
cbdMD, Inc. and Twinlab Consolidated Holdings, Inc. entered the Exit Mode archive.
- Buyer
- cbdMD, Inc.
- Target
- Twinlab Consolidated Holdings, Inc.
- Deal value
- Not disclosed
- Deal type
- strategic acquisition
KIMBERLY-CLARK to acquire KENVUE
KIMBERLY-CLARK and KENVUE entered the Exit Mode archive.
- Buyer
- KIMBERLY-CLARK
- Target
- KENVUE
- Deal value
- Not disclosed
- Deal type
- strategic acquisition
Frasers Group plc to acquire Harvey Nichols
Frasers Group plc has agreed to acquire Harvey Nichols in a strategic acquisition within the consumer and retail sector. The transaction involves the purchase of the lux…
- Buyer
- Frasers Group plc
- Target
- Harvey Nichols
- Deal value
- Not disclosed
- Deal type
- strategic acquisition
Buyer history
Mentholatum Australasia Pty Ltd
See every published Exit Mode archive entry where this buyer appears.
View buyer profileMethodology
How this page is built
Layer 1 facts come from source documents, Layer 2 turns those facts into a readable narrative, and Layer 3 only appears where the editorial team flags a founder-relevant deal.
Back to the archive